GRK6
Basic information
Region (hg38): 5:177403204-177442901
Previous symbols: [ "GPRK6" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GRK6 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 2 | 0 |
Variants in GRK6
This is a list of pathogenic ClinVar variants found in the GRK6 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-177403242-A-G | Benign (Nov 11, 2022) | |||
5-177403255-C-G | Hereditary angioedema type 3 | Uncertain significance (-) | ||
5-177403267-G-T | Likely benign (Jul 30, 2022) | |||
5-177403267-GC-G | Factor XII deficiency disease | Likely pathogenic (-) | ||
5-177403293-T-C | Uncertain significance (Nov 01, 2022) | |||
5-177403300-G-C | Likely benign (Dec 01, 2023) | |||
5-177403311-C-T | Inborn genetic diseases | Uncertain significance (Nov 08, 2022) | ||
5-177403323-G-A | Factor XII deficiency disease | Uncertain significance (Mar 29, 2024) | ||
5-177403325-A-G | Inborn genetic diseases | Uncertain significance (Mar 01, 2023) | ||
5-177403348-C-A | Benign (Feb 08, 2023) | |||
5-177403350-A-G | Uncertain significance (Dec 20, 2023) | |||
5-177403357-C-T | Likely benign (Oct 26, 2023) | |||
5-177403367-C-T | Inborn genetic diseases | Uncertain significance (Dec 02, 2021) | ||
5-177403432-G-A | Benign (Nov 11, 2018) | |||
5-177403477-G-C | Factor XII deficiency disease • Hereditary angioedema type 3 | Conflicting classifications of pathogenicity (Jul 01, 2023) | ||
5-177403514-C-T | Uncertain significance (Sep 12, 2022) | |||
5-177403525-C-T | Uncertain significance (Nov 24, 2023) | |||
5-177403526-G-A | Hereditary angioneurotic edema • Factor XII deficiency disease • Nephrolithiasis/osteoporosis, hypophosphatemic • Hereditary angioedema type 3 • F12-related disorder | Benign/Likely benign (Jan 22, 2024) | ||
5-177403539-G-A | Likely benign (Jul 13, 2023) | |||
5-177403554-C-T | Likely benign (May 12, 2022) | |||
5-177403569-G-A | Nephrolithiasis/osteoporosis, hypophosphatemic • Factor XII deficiency disease • Hereditary angioneurotic edema • Hereditary angioedema type 3 • F12-related disorder | Benign/Likely benign (Dec 01, 2023) | ||
5-177403596-C-G | Nephrolithiasis/osteoporosis, hypophosphatemic • Hereditary angioneurotic edema • Factor XII deficiency disease • Hereditary angioedema type 3 • Factor XII deficiency disease;Hereditary angioedema type 3 • F12-related disorder | Benign/Likely benign (Nov 17, 2023) | ||
5-177403612-G-A | Thrombus | Uncertain significance (-) | ||
5-177403621-CG-C | F12-related disorder | Likely benign (Jun 06, 2019) | ||
5-177403621-C-CG | F12-related disorder | Benign/Likely benign (Nov 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GRK6 | protein_coding | protein_coding | ENST00000528793 | 16 | 39698 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000487 | 0.999 | 125732 | 0 | 12 | 125744 | 0.0000477 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.81 | 234 | 390 | 0.600 | 0.0000266 | 3824 |
Missense in Polyphen | 70 | 160.75 | 0.43547 | 1671 | ||
Synonymous | 0.165 | 159 | 162 | 0.983 | 0.0000113 | 1137 |
Loss of Function | 3.50 | 12 | 34.1 | 0.352 | 0.00000163 | 375 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000919 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000546 | 0.0000544 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.0000632 | 0.0000615 |
Middle Eastern | 0.0000546 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Specifically phosphorylates the activated forms of G protein-coupled receptors. Such receptor phosphorylation initiates beta-arrestin-mediated receptor desensitization, internalization, and signaling events leading to their desensitization. Seems to be involved in the desensitization of D2-like dopamine receptors in striatum and chemokine receptor CXCR4 which is critical for CXCL12-induced cell chemotaxis (By similarity). Phosphorylates rhodopsin (RHO) (in vitro) and a non G-protein-coupled receptor: LRP6 during Wnt signaling (in vitro). {ECO:0000250, ECO:0000269|PubMed:19801552, ECO:0000269|PubMed:20048153}.;
- Pathway
- Endocytosis - Homo sapiens (human);Chemokine signaling pathway - Homo sapiens (human);Morphine addiction - Homo sapiens (human);HH-Ncore;Follicle Stimulating Hormone (FSH) signaling pathway;Corticotropin-releasing hormone signaling pathway;Myometrial Relaxation and Contraction Pathways;Chemokine signaling pathway;Calcium Regulation in the Cardiac Cell;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;CRH;IL-7 signaling;CXCR4-mediated signaling events;JAK STAT pathway and regulation;EPO signaling;VEGF;GPCR downstream signalling;FSH
(Consensus)
Recessive Scores
- pRec
- 0.207
Intolerance Scores
- loftool
- 0.549
- rvis_EVS
- -0.24
- rvis_percentile_EVS
- 36.17
Haploinsufficiency Scores
- pHI
- 0.506
- hipred
- Y
- hipred_score
- 0.704
- ghis
- 0.546
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.997
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Grk6
- Phenotype
- homeostasis/metabolism phenotype; renal/urinary system phenotype; immune system phenotype; hematopoietic system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- protein phosphorylation;G protein-coupled receptor signaling pathway;regulation of G protein-coupled receptor signaling pathway;Wnt signaling pathway
- Cellular component
- plasma membrane;membrane
- Molecular function
- G protein-coupled receptor kinase activity;protein binding;ATP binding;beta-adrenergic receptor kinase activity